Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRNB

Principia Biopharma (PRNB) Stock Price, News & Analysis

Principia Biopharma logo

About Principia Biopharma Stock (NASDAQ:PRNB)

Advanced Chart

Key Stats

Today's Range
$100.05
$100.05
50-Day Range
$99.95
$100.27
52-Week Range
$25.35
$101.89
Volume
N/A
Average Volume
729,676 shs
Market Capitalization
$3.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Principia Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PRNB Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
Principia College names new president
See More Headlines

PRNB Stock Analysis - Frequently Asked Questions

Principia Biopharma Inc. (NASDAQ:PRNB) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of ($1.03) by $1.34. The business earned $50 million during the quarter, compared to analysts' expectations of $50 million.

Principia Biopharma (PRNB) raised $75 million in an IPO on Friday, September 14th 2018. The company issued 4,700,000 shares at $15.00-$17.00 per share. BofA Merrill Lynch, Leerink Partners and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Principia Biopharma investors own include Pfizer (PFE), Advanced Micro Devices (AMD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Cisco Systems (CSCO), QUALCOMM (QCOM) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
8/06/2020
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PRNB
CIK
N/A
Fax
N/A
Employees
65
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-23.08%
Return on Assets
-21.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.01
Quick Ratio
17.01

Sales & Book Value

Annual Sales
$35.16 million
Price / Sales
94.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.95 per share
Price / Book
9.14

Miscellaneous

Outstanding Shares
33,209,000
Free Float
N/A
Market Cap
$3.32 billion
Optionable
Not Optionable
Beta
0.86
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:PRNB) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners